Comorbidity

Latest News

Here are highlights from the week in Psychiatric Times.
The Week in Review: May 13-17

May 18th 2024

Here are highlights from the week in Psychiatric Times.

The study sheds light on the potential risks and adverse effects of polypharmacy in patients with complex psychiatric conditions.
Examining a Case of Psychiatric Polypharmacy-Related Agranulocytosis

May 17th 2024

What is new in research on posttraumatic stress disorder?
PTSD Research Roundup: April 26, 2024

April 26th 2024

What is new in research on opioid use disorder?
Opioid Use Disorder Research Roundup: April 19, 2024

April 19th 2024

From personality disorders and common comorbidities to the effects of abortion bans on mental health, here are highlights from the week in Psychiatric Times.
The Week in Review: February 26-March 1

March 2nd 2024

Latest CME Events & Activities

Real Psychiatry 2025

January 17 - 18, 2025

View More

More Than ‘Blue’ After Birth: Managing Diagnosis and Treatment of Post-Partum Depression

View More

Patient, Provider & Caregiver Connection™: Reducing the Burden of Parkinson Disease Psychosis with Personalized Management Plans

View More

Expert Perspectives in the Recognition and Management of Postpartum Depression

View More

Southern California Psychiatry Conference

July 11-12, 2025

Register Now!

SimulatED™: Diagnosing and Treating Alzheimer’s Disease in the Modern Era

View More

Expert Illustrations & Commentaries™: New Targets for Treatment in Cognitive Impairment in Schizophrenia – The Role of NMDA Receptors and Co-agonists

View More

BURST CME™ Part I: Understanding the Impact of Huntington’s Disease

View More

Burst CME™ Part II: The Evolving Treatment Landscape for Huntington Disease

View More

Clinical ShowCase: Developing a Personalized Treatment Plan for a Patient with Huntington’s Disease Associated Chorea

View More

Stabilize and Thrive: Prioritizing Patient Success Through Novel Therapeutic Management in Schizophrenia

View More

Community Practice Connections™: Optimizing the Management of Tardive Dyskinesia—Addressing the Complexity of Care With Targeted Treatment

View More

PER Psych Summit: Integrating Shared Decision-Making Into Management Plans for Patients With Schizophrenia

View More

More News

© 2024 MJH Life Sciences

All rights reserved.